Japan, Sept. 16 -- FUJIFILM CORP,OSAKA UNIV has got intellectual property rights for 'METHOD OF PREDICTING THERAPEUTIC EFFECT OF IMMUNE CHECKPOINT INHIBITOR, METHOD OF ACQUIRING DATA FOR PREDICTING THERAPEUTIC EFFECT, AND TEST KIT FOR MEASURING PROHAPTOGLOBIN LEVEL IN METHOD OF PREDICTING THERAPEUTIC EFFECT OR METHOD OF ACQUIRING DATA.' Other related details are as follows:
Application Number: JP,2023-049014
Category (FI): C07K16/18,G01N33/68,G01N33/543,501@A,G01N33/53@V
Stage: PROBLEM TO BE SOLVED: To provide a method of predicting therapeutic effect of a novel immune checkpoint inhibitor, a method of acquiring data for predicting the therapeutic effect, and a test kit for measuring the level of prohaptoglobin in the method of predicting the therapeutic effect or the method of acquiring the data.SOLUTION: The present invention relates to: a method of predicting therapeutic effect of an immune checkpoint inhibitor in a subject, the method comprising measuring the level of prohaptoglobin in a sample collected from the subject; a method of acquiring data for predicting the therapeutic effect; and a test kit for measuring the level of prohaptoglobin in the method of predicting the therapeutic effect or the method of acquiring the data.SELECTED DRAWING: Figure 3 (Grant)
Filing Date: March 24, 2023
Publication Date: Oct. 7, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
